Episode 42: Vedicinals9 - Joachim Gerlach

As yet, no one has discovered the mechanisms behind Post Covid Syndrome and the established medical system is failing to offer any proven treatments, so more and more Long Covid sufferers are turning to alternative therapies. One of these new ‘therapies’ is a nutraceutical called Vedicinals9.

Nutraceutical products can be considered non-specific biological therapies used to promote general well-being, control symptoms, and prevent malignant processes. The word “nutraceutical” combines the two words of “nutrient,” which is a nourishing food component, and “pharmaceutical,” which is a medical drug. However, nutraceuticals are not drugs, but a sector of the supplements market made only from whole foods.

We spoke to Vedicinals Chairman, Joachim Gerlach, about his long-term commitment to finding help for those suffering chronic disease, which started years before the pandemic began. A German entrepreneur, Gerlach has pivoted his focus and used his savings to develop this nutraceutical, consisting of nine bio-active molecules targeting specific pathways, in collaboration with Indian doctors and scientists, drawing on age-old ayurvedic traditions alongside modern science.

Contrary to many other nutraceuticals and supplements, Vedicinals9 has undergone extensive safety studies, including looking at toxicity and myocardial infarction, and a WHO registered randomised clinical trial. Gerlach does warn of interactions with other drugs so do seek advice before taking it.

Gerlach is now creating a global coalition, bringing together scientists and companies, research and strategies, to create a body of knowledge about Long Covid to further understand and treat the disease.